902837-45-0 Usage
Uses
Used in Pharmaceutical Industry:
3-IODO-2-PROPOXY-PYRIDINE is used as a key intermediate in the synthesis of various pharmaceuticals for its potential role in the development of new drugs. Its unique structure contributes to the creation of molecules with specific therapeutic properties.
Used in Agrochemical Industry:
In the agrochemical sector, 3-IODO-2-PROPOXY-PYRIDINE serves as an intermediate in the synthesis of pesticides, leveraging its chemical properties to enhance the effectiveness of these products in agricultural applications.
Used in Antimicrobial and Anti-Fungal Agents Development:
3-IODO-2-PROPOXY-PYRIDINE is utilized in the research and development of antimicrobial and antifungal agents due to its demonstrated activities against certain microorganisms, which can be harnessed to create new treatments and preventive measures in medicine and agriculture.
Check Digit Verification of cas no
The CAS Registry Mumber 902837-45-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,0,2,8,3 and 7 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 902837-45:
(8*9)+(7*0)+(6*2)+(5*8)+(4*3)+(3*7)+(2*4)+(1*5)=170
170 % 10 = 0
So 902837-45-0 is a valid CAS Registry Number.
902837-45-0Relevant articles and documents
BIARYL DERIVATIVE AS GPR120 AGONIST
-
Paragraph 0145, (2017/11/17)
The present invention relates to a biaryl derivative expressed by the chemical formula 1, a method for producing the biaryl derivative, a pharmaceutical composition comprising same, and use of same, the biaryl derivative expressed by the chemical formula 1, as a GPR120 agonist, promoting GLP-1 generation in the gastro-intestinal tract, reducing insulin resistance in the liver, muscles and the like from anti-inflammatory activity in the macrophage, pancreatic cells and the like, and allowing effective use in prevention or treatment of inflammation or metabolic diseases such as diabetes, complications from diabetes, obesity, non-alcoholic fatty liver disease, fatty liver disease, and osteoporosis.
